Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure
- 25 July 2000
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (15), 1344-1349
- https://doi.org/10.1038/sj.gt.3301229
Abstract
The liver is an important target organ for gene transfer due to its large capacity for synthesizing serum proteins and its involvement in numerous genetic and acquired diseases. Previously, we and others have shown that an efficient gene transfer to liver cells in vivo can be achieved by an intravenous injection of plasmid DNA using a hydrodynamics-based procedure. In this study, we systematically characterized the expression of transgene encoding a secretory protein in mouse. Using human α1-antitrypsin (hAAT) gene as a reporter, we demonstrate that the serum level of hAAT can reach as high as 0.5 mg/ml by a simple tail vein injection of 10–50 μg plasmid DNA into a mouse. The serum hAAT reaches the peak level 1 day after DNA injection and then declines during the following 2 to 4 weeks to 2–5 μg/ml, a level which persists for at least 6 months. Southern analysis of extracted DNA and RT-PCR analysis of RNA from the liver reveal that hAAT gene is active and present as episomal form after 6 months. These results suggest that the hydrodynamics-based transfection procedure provides a valuable tool for screening genes for therapeutic purposes in whole animals.Keywords
This publication has 32 references indexed in Scilit:
- High Levels of Foreign Gene Expression in Hepatocytes after Tail Vein Injections of Naked Plasmid DNAHuman Gene Therapy, 1999
- Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicityNature Genetics, 1998
- Expression of Naked Plasmid DNA Injected into the Afferent and Efferent Vessels of Rodent and Dog LiversHuman Gene Therapy, 1997
- Highly Efficient Retrovirus-Mediated Gene Transfer into Rat HepatocytesIn VivoHuman Gene Therapy, 1997
- Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectorsNature Genetics, 1997
- Quantitative Analysis of the Packaging Capacity of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1996
- Assessment of Recombinant Adenoviral Vectors for Hepatic Gene TherapyHuman Gene Therapy, 1993
- Adenovirus–mediated in vivo gene transfer and expression in normal rat liverNature Genetics, 1992
- Persistent Gene Expression After Retroviral Gene Transfer into Liver CellsIn VivoHuman Gene Therapy, 1991
- Structure and variation of human α1–antitrypsinNature, 1982